These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37769625)

  • 1. Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
    Shen C; Zhang DL; Cheng XL; Zhang WC; Zhao JJ
    Urol Int; 2023; 107(9):841-847. PubMed ID: 37769625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
    Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
    Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
    J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy.
    Li H; Ding JY; Zhang MJ; Yu HJ; Sun ZJ
    Cancer Lett; 2023 Aug; 568():216293. PubMed ID: 37392991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
    Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
    Front Immunol; 2022; 13():868155. PubMed ID: 35664009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
    Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
    Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
    Chen J; Chen J; Wang L
    J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary lymphoid structures and their therapeutic implications in cancer.
    Chen X; Wu P; Liu Z; Li T; Wu J; Zeng Z; Guo W; Xiong W
    Cell Oncol (Dordr); 2024 Oct; 47(5):1579-1592. PubMed ID: 39133439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients.
    Zhang K; Xie X; Zou LH; Guo SQ
    Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response.
    Zhang Q; Wu S
    Front Immunol; 2022; 13():1063711. PubMed ID: 36713409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
    An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
    Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
    Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
    Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer.
    Weng Y; Yuan J; Cui X; Wang J; Chen H; Xu L; Chen X; Peng M; Song Q
    Sci Rep; 2024 Jul; 14(1):16246. PubMed ID: 39009684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.
    Zhao L; Jin S; Wang S; Zhang Z; Wang X; Chen Z; Wang X; Huang S; Zhang D; Wu H
    Signal Transduct Target Ther; 2024 Aug; 9(1):225. PubMed ID: 39198425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary lymphoid structures in autoimmune diseases.
    Dong Y; Wang T; Wu H
    Front Immunol; 2023; 14():1322035. PubMed ID: 38259436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer.
    Gu J; Wang J; Sun Y; Mao X; Qian C; Tang X; Wang J; Xie H; Ling L; Zhao Y; Liu X; Zhang K; Pan H; Wang S; Wang C; Zhou W
    Cancer Med; 2024 Jan; 13(1):e6864. PubMed ID: 38133211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma.
    Sun H; Liu Y; Cheng W; Xiong R; Gu W; Zhang X; Wang X; Wang X; Tan C; Weng W; Zhang M; Ni S; Huang D; Xu M; Sheng W; Wang L
    Front Immunol; 2024; 15():1396808. PubMed ID: 39136032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
    Yamakoshi Y; Tanaka H; Sakimura C; Deguchi S; Mori T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
    Int J Oncol; 2020 Jul; 57(1):171-182. PubMed ID: 32319601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.